Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care.

PMID: 35106697 ·

B, r, i, a, n, , G, , B, e, i, t, l, e, r, ;, , P, a, u, l, , F, , A, b, r, a, h, a, m, ;, , A, l, y, s, s, a, , R, , G, l, e, n, n, o, n, ;, , S, t, e, v, e, n, , M, , T, o, m, m, a, s, i, n, i, ;, , L, i, s, a, , L, , L, a, t, t, a, n, z, a, ;, , J, o, n, a, t, h, a, n, , M, , M, o, r, r, i, s, ;, , D, a, n, i, e, l, , H, , W, i, z, n, i, a

Journal3D printing in medicine
Year
PMID35106697

Abstract

3D printing is revolutionizing the medical device landscape through its ability to rapidly create patient-specific anatomic models, surgical instruments, and implants. Recent advances in 3D printing technology have allowed for the creation of point-of-care (PoC) 3D printing centers. These PoC centers blur the line between healthcare provider, medical center, and device manufacturer, creating regulatory ambiguity. The United States Food & Drug Administration (FDA) currently regulates 3D printed d

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑